Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Hepatitis B virus and HIV co-infection among pregnant women in Rwanda

Authors: Mwumvaneza Mutagoma, Helene Balisanga, Samuel S. Malamba, Dieudonné Sebuhoro, Eric Remera, David J. Riedel, Steve Kanters, Sabin Nsanzimana

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Hepatitis B virus (HBV) affects people worldwide but the local burden especially in pregnant women and their new born babies is unknown. In Rwanda HIV-infected individuals who are also infected with HBV are supposed to be initiated on ART immediately. HBV is easily transmitted from mother to child during delivery. We sought to estimate the prevalence of chronic HBV infection among pregnant women attending ante-natal clinic (ANC) in Rwanda and to determine factors associated with HBV and HIV co-infection.

Methods

This study used a cross-sectional survey, targeting pregnant women in sentinel sites. Pregnant women were tested for hepatitis B surface antigen (HBsAg) and HIV infection. A series of tests were done to ensure high sensitivity. Multivariable logistic regression was used to identify independent predictors of HBV-HIV co-infection among those collected during ANC sentinel surveillance, these included: age, marital status, education level, occupation, residence, pregnancy and syphilis infection.

Results

The prevalence of HBsAg among 13,121 pregnant women was 3.7% (95% CI: 3.4–4.0%) and was similar among different socio-demographic characteristics that were assessed. The proportion of HIV-infection among HBsAg-positive pregnant women was 4.1% [95% CI: 2.5–6.3%]. The prevalence of HBV-HIV co-infection was higher among women aged 15-24 years compared to those women aged 25–49 years [aOR = 6.9 (95% CI: 1.8–27.0)]. Women residing in urban areas seemed having HBV-HIV co-infection compared with women residing in rural areas [aOR = 4.3 (95% CI: 1.2–16.4)]. Women with more than two pregnancies were potentially having the co-infection compared to those with two or less (aOR = 6.9 (95% CI: 1.7–27.8). Women with RPR-positive test were seemed associated with HBV-HIV co-infection (aOR = 24.9 (95% CI: 5.0–122.9).

Conclusion

Chronic HBV infection is a public health problem among pregnant women in Rwanda. Understanding that HBV-HIV co-infection may be more prominent in younger women from urban residences will help inform and strengthen HBV prevention and treatment programmes among HIV-infected pregnant women, which is crucial to this population.
Literature
1.
go back to reference World Health Organization. Global hepatitis report. 2017. World Health Organization. Global hepatitis report. 2017.
2.
go back to reference World Health Organization. Management of hepatitis B and HIV coinfection. Geneva; 2011. World Health Organization. Management of hepatitis B and HIV coinfection. Geneva; 2011.
3.
go back to reference Hwang E W, Cheung R. Global epidemiology of Hepatitis B Virus (HBV) infection. N A J Med Sci. 2011;4(1):7-13. Hwang E W, Cheung R. Global epidemiology of Hepatitis B Virus (HBV) infection. N A J Med Sci. 2011;4(1):7-13.
4.
go back to reference Ott JJ, Stevens GA, Groeger J, et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9.CrossRefPubMed Ott JJ, Stevens GA, Groeger J, et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9.CrossRefPubMed
5.
go back to reference Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–25.CrossRefPubMed Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–25.CrossRefPubMed
8.
go back to reference Ochola E, Ocama P, Orach CG, et al. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health. 2013;13:727.CrossRefPubMedPubMedCentral Ochola E, Ocama P, Orach CG, et al. High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health. 2013;13:727.CrossRefPubMedPubMedCentral
9.
11.
go back to reference Gasim GI, Murad IA, Adam I. Hepatitis B and C virus infections among pregnant women in Arab and African countries. J Infect Dev Ctries. 2013;7(8):566–78.CrossRefPubMed Gasim GI, Murad IA, Adam I. Hepatitis B and C virus infections among pregnant women in Arab and African countries. J Infect Dev Ctries. 2013;7(8):566–78.CrossRefPubMed
12.
go back to reference Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104.
13.
go back to reference Olokoba AB, Salawu FK, Danburam A, et al. Hepatitis B infection amongst pregnant women in Noth-eastern Nigeria – a call for action. Niger J Clin Pract. 2011;14(1):1–13.CrossRef Olokoba AB, Salawu FK, Danburam A, et al. Hepatitis B infection amongst pregnant women in Noth-eastern Nigeria – a call for action. Niger J Clin Pract. 2011;14(1):1–13.CrossRef
14.
go back to reference Rashid S, Kilewo C, Aboud S. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es salaam, Tanzania. Tanzan J Health Res. 2014:16(1). Rashid S, Kilewo C, Aboud S. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es salaam, Tanzania. Tanzan J Health Res. 2014:16(1).
15.
go back to reference MacLean B, Hess RF, Bonvillain E, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J. 2012;102(1):47–9. MacLean B, Hess RF, Bonvillain E, et al. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. S Afr Med J. 2012;102(1):47–9.
16.
go back to reference Noubiap JJN, Nansseu JRN JRN, Ndoula ST, et al. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the far North Region of Cameroon. BMC Public Health. 2015;15:454.CrossRefPubMedPubMedCentral Noubiap JJN, Nansseu JRN JRN, Ndoula ST, et al. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the far North Region of Cameroon. BMC Public Health. 2015;15:454.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 Suppl):S138–45.CrossRefPubMed Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 Suppl):S138–45.CrossRefPubMed
19.
go back to reference Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes. 2013;6:363.CrossRefPubMedPubMedCentral Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes. 2013;6:363.CrossRefPubMedPubMedCentral
20.
go back to reference Pirillo MF, Bassani L, Germinario EAP, et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol. 2007;79:1797–801.CrossRefPubMed Pirillo MF, Bassani L, Germinario EAP, et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol. 2007;79:1797–801.CrossRefPubMed
22.
go back to reference Nsanzimana S, Kanters S, Remera E, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2(5):e208–15.CrossRefPubMed Nsanzimana S, Kanters S, Remera E, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2(5):e208–15.CrossRefPubMed
23.
go back to reference Ezechi OC, Kalejaiye OO, Gab-Okafor CV, et al. Sero-prevalence and factors associated with hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection. Pan Afr Med J. 2014;17:197.CrossRefPubMedPubMedCentral Ezechi OC, Kalejaiye OO, Gab-Okafor CV, et al. Sero-prevalence and factors associated with hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection. Pan Afr Med J. 2014;17:197.CrossRefPubMedPubMedCentral
24.
go back to reference Hoffmann CJ, Mashabela F, Cohn S, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014;17:18871.CrossRefPubMedPubMedCentral Hoffmann CJ, Mashabela F, Cohn S, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014;17:18871.CrossRefPubMedPubMedCentral
25.
go back to reference Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118.CrossRefPubMedPubMedCentral Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118.CrossRefPubMedPubMedCentral
Metadata
Title
Hepatitis B virus and HIV co-infection among pregnant women in Rwanda
Authors
Mwumvaneza Mutagoma
Helene Balisanga
Samuel S. Malamba
Dieudonné Sebuhoro
Eric Remera
David J. Riedel
Steve Kanters
Sabin Nsanzimana
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2714-0

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue